These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12168935)

  • 1. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
    Shen YY; Shiau YC; Wang JJ; Ho ST; Kao CH
    Anticancer Res; 2002; 22(2B):1257-64. PubMed ID: 12168935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
    Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
    J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
    Kut V; Spies W; Spies S; Gooding W; Argiris A
    Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
    Niho S; Fujii H; Murakami K; Nagase S; Yoh K; Goto K; Ohmatsu H; Kubota K; Sekiguchi R; Nawano S; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Sep; 57(3):328-33. PubMed ID: 17537538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
    Brink I; Schumacher T; Mix M; Ruhland S; Stoelben E; Digel W; Henke M; Ghanem N; Moser E; Nitzsche EU
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1614-20. PubMed ID: 15258700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
    Sohn BS; Lee DH; Kim EK; Yoon DH; Kim HO; Ryu JS; Kim SW; Suh C
    Onkologie; 2012; 35(7-8):432-8. PubMed ID: 22846975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of fluorine-18 fluorode oxyglucose-positron emission tomography in patients with small cell lung cancer].
    Yu CH; Wang T; Yin DY; Sun YE; Tian JH; Yao SL
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):229-32. PubMed ID: 15059541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
    Kamel EM; Zwahlen D; Wyss MT; Stumpe KD; von Schulthess GK; Steinert HC
    J Nucl Med; 2003 Dec; 44(12):1911-7. PubMed ID: 14660716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET imaging for the staging and follow-up of small cell lung cancer.
    Schumacher T; Brink I; Mix M; Reinhardt M; Herget G; Digel W; Henke M; Moser E; Nitzsche E
    Eur J Nucl Med; 2001 Apr; 28(4):483-8. PubMed ID: 11357499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer.
    Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R
    J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
    Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
    Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study.
    Chin R; McCain TW; Miller AA; Dunagan DP; Acostamadiedo J; Douglas Case L; Harkness BA; Adler LP; Haponik EF
    Lung Cancer; 2002 Jul; 37(1):1-6. PubMed ID: 12057859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer.
    Pandit N; Gonen M; Krug L; Larson SM
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):78-84. PubMed ID: 12483413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
    Zhao DS; Valdivia AY; Li Y; Blaufox MD
    Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 18F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra-pulmonary small-cell cancer.
    Gregory DL; Brennan SM; Stillie A; Herschtal A; Hicks RJ; MacManus MP; Ball DL
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):100-7. PubMed ID: 20518871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
    Arslan N; Tuncel M; Kuzhan O; Alagoz E; Budakoglu B; Ozet A; Ozguven MA
    Ann Nucl Med; 2011 Jul; 25(6):406-13. PubMed ID: 21409347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
    Cheran SK; Herndon JE; Patz EF
    Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.
    Blum R; MacManus MP; Rischin D; Michael M; Ball D; Hicks RJ
    Am J Clin Oncol; 2004 Apr; 27(2):164-71. PubMed ID: 15057156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.